Skip to main content Skip to main navigation menu Skip to site footer
Emblem of the journal "Research Results in Pharmacology"
  • About
    • Focus and Scope
    • Editorial Policies
    • Submission Guidelines
    • Section Policies
    • Guidelines for Editors
    • Guidelines for Reviewers
    • Publication Ethics and Malpractice Statement
    • Terms of Use
    • Cookies Policy
  • Authors Guidelines
  • Articles
  • Issues
  • Editorial Team
    • Editorial Board
    • Subject Editors
  • Contacts
Search
  • Submit manuscript
  • Register
  • Login
  1. Home /
  2. Archives /
  3. Vol. 11 No. 3 (2025)
  • Review article

    Orthogonal approach and critical quality attributes for gene and cell therapy products

    Ekaterina V. Melnikova, Marina A. Vodyakova, Nikita S. Pokrovsky, Vadim A. Merkulov
    87-97
    https://doi.org/10.18413/rrpharmacology.11.738
    30-09-2025 Abstract: 35 | PDF: 18 | HTML: 11 |
    • PDF
    • HTML
  • Experimental Pharmacology

    Anxiolytic, antidepressant and analgesic activities of novel derivatives of 1-(3-phenylpyrrol-2-yl)-1,3-dihydro-2H-benzimidazol-2-one

    Maria О. Maltseva, Kristina I. Adzhienko, Raul I. Musaev, Alexander A. Spasov, Vahid A. Mamedov, Natalia A. Zhukova, Sevil V. Mamedova, Nalatalia V. Eliseeva, Karina R. Magomedova, Dmitriy V. Maltsev
    16-25
    https://doi.org/10.18413/rrpharmacology.11.802
    27-09-2025 Abstract: 56 | PDF: 34 | HTML: 30 |
    • PDF
    • HTML
  • Experimental Pharmacology

    Properties and antitumor activity of combined polymeric nanoparticles based on gefitinib and a photosensitizer

    Lyudmila L. Nikolaeva, Anna V. Lantsova, Maria A. Baryshnikova, Anna Rudakova, Olga L. Orlova, Natalia D. Bunyatyan, Alina A. Markova, Vladimir A. Kuzmin, Ekaterina V. Sanarova
    52-60
    https://doi.org/10.18413/rrpharmacology.11.600
    30-09-2025 Abstract: 26 | PDF: 29 | HTML: 23 |
    • PDF
    • HTML
  • Experimental Pharmacology

    The prefrontal cortex as a target for the atypical antipsychotic RU-31 with 5-HT2A antagonistic activity in the treatment of cognitive symptoms

    Konstantin Y. Kalitin, Olga Y. Mukha, Viktor B. Voynov, Alexander A. Spasov
    98-108
    https://doi.org/10.18413/rrpharmacology.11.537
    30-09-2025 Abstract: 30 | PDF: 11 | HTML: 11 |
    • PDF
    • HTML
  • Experimental Pharmacology

    Comparison of CD-1 and ICR mouse strains for impulsivity in the enriched cross-maze test: Effects of atomoxetine

    Ramiz M. Salimov, Natalia А. Sukhorukova, Georgy I. Kovalev
    10-15
    https://doi.org/10.18413/rrpharmacology.11.724
    27-09-2025 Abstract: 58 | PDF: 20 | HTML: 24 |
    • PDF
    • HTML
  • Clinical Pharmacology

    Pharmacoepidemiological analysis of drug therapy for asthenic syndrome as provided in Kaliningrad region

    Yana D. Belousova, Nadezhda O. Kryukova, Iuliia A. Filimonkina , Vladimir V. Rafalskiy
    37-43
    https://doi.org/10.18413/rrpharmacology.11.586
    27-09-2025 Abstract: 25 | PDF: 17 | HTML: 7 |
    • PDF
    • HTML
  • Clinical Pharmacology

    Correction of protein and lipid spectra of erythrocyte membranes as a pathogenetic supplement to the therapy of coronary heart disease

    Svetlana G. Dorofeeva, Eugenia N. Konoplya, Oksana V. Mansimova
    1-9
    https://doi.org/10.18413/rrpharmacology.11.718
    01-07-2025 Abstract: 487 | PDF: 194 | HTML: 232 |
    • PDF
    • HTML
  • Clinical Pharmacology

    Role of visfatin, sirtuin 1 and apelin in patients with autism disorder

    Feryal Rada
    44-51
    https://doi.org/10.18413/rrpharmacology.11.578
    30-09-2025 Abstract: 17 | PDF: 14 | HTML: 11 |
    • PDF
    • HTML
  • Clinical Pharmacology

    Adherence to dual antiplatelet therapy among outpatients after acute myocardial infarction in primary care

    Sergey B. Fitilev, Alexander V. Vozzhaev, Irina I. Shkrebniova, Dmitry A. Klyuev, Anna O. Ovaeva, Darya K. Barsukova
    26-36
    https://doi.org/10.18413/rrpharmacology.11.752
    27-09-2025 Abstract: 61 | PDF: 17 | HTML: 15 |
    • PDF
    • HTML
  • Pharmacological reviews

    Nonclassical cardiovascular effects of imidazoline receptor agonists

    Yulia V. Stepenko, Olesya V. Shcheblykina, Anna A. Peresypkina, Veronika S. Shmigerova, Yomna Y.O.M. Akhmed , Tatiana A. Denisyuk, Anton P. Danilenko; Nikita S. Lyapkalov; Elena A. Shmykova, Lyudmila M. Danilenko
    77-86
    https://doi.org/10.18413/rrpharmacology.11.640
    30-09-2025 Abstract: 34 | PDF: 24 | HTML: 13 |
    • PDF
    • HTML
  • Pharmacological reviews

    A drug as a two-faced Janus: dose-effect, adverse events

    Sofia Ya. Skachilova, Ekaterina A. Simakina, Andrey V. Denisenko, Elena V. Shilova, Anna L. Motailo, Aleksey A. Khentov
    61-76
    https://doi.org/10.18413/rrpharmacology.11.561
    30-09-2025 Abstract: 33 | PDF: 11 | HTML: 10 |
    • PDF
    • HTML
  • Short Communication

    Regulation of 11β-hydroxysteroid dehydrogenase isoforms – novel drug targets for osteoporosis therapy

    Ivan S. Koklin, Petr R. Lebedev, Alim A. Kochkarov, Oleg S. Gudyrev, Vladimir V. Gureev, Aleksandr A. Dolzhikov, Eduard I. Taran, Mikhail V. Korokin
    109-114
    https://doi.org/10.18413/rrpharmacology.11.807
    30-09-2025 Abstract: 2 | PDF: 1 | HTML: 3 |
    • PDF
    • HTML
  • 1
  • 2
  • 3
  • 4
  • 5
  • ..

Language

  • Русский
  • English

Journal "Research Results in Pharmacology" (ISSN 2658-381X)

The Founder: Federal State Autonomous Educational Institution of Higher Education "Belgorod National Research University"
The Founder’s address: 85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia.

The Publisher: Federal State Autonomous Educational Institution of Higher Education "Belgorod National Research University"
The Publisher’s address: 85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia.

Chief Editor: Pokrovskii M.V.

Editors Office: e-mail: rr_pharmacology@bsuedu.ru, phone: +7 (4722) 30-13-73.

The Journal registered by the Federal Service for Supervision of Communications, Information Technology and Mass Media (Roskomnadzor).
Certificate ЭЛ № ФС77-73012 (06.06.2018).

 

More information about the publishing system, Platform and Workflow by OJS/PKP.